Patient Guide: An Open-label, Single-arm Study of Prophylaxis for Datopotamab Deruxtecan (Dato-DXd) -Related Stomatitis in Eligible Patients With Metastatic or Inoperable Locally Recurrent Breast Cancer or Locally Advanced or Metastatic Epidermal Growth Factor Receptor-Mutated Non-small Cell Lung Cancer.

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • ✓ Get matched to the right study location for you
  • ✓ Connect directly with study coordinators at 40 participating sites
  • ✓ Understand eligibility with our simplified screening tool
  • ✓ Free service - we're here to help you access clinical research
Trial ID: NCTNCT07357597
Status: 🟢 Enrolling Now
Condition: Stomatitis
Phase: Phase IV

Find a Study Location Near You

This study is available at 40 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • • Tucson, Arizona
  • • Hot Springs, Arkansas
  • • Little Rock, Arkansas
  • • And 37 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily